164 related articles for article (PubMed ID: 15172050)
21. Update on cytokines in rheumatoid arthritis.
Brennan F; Beech J
Curr Opin Rheumatol; 2007 May; 19(3):296-301. PubMed ID: 17414959
[TBL] [Abstract][Full Text] [Related]
22. Targeting the interleukin-15 system in rheumatoid arthritis.
Waldmann TA
Arthritis Rheum; 2005 Sep; 52(9):2585-8. PubMed ID: 16142738
[No Abstract] [Full Text] [Related]
23. Therapeutic strategies for rheumatoid arthritis.
Smolen JS; Steiner G
Nat Rev Drug Discov; 2003 Jun; 2(6):473-88. PubMed ID: 12776222
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-18 treatment options for inflammatory diseases.
Dinarello CA; Kaplanski G
Expert Rev Clin Immunol; 2005 Nov; 1(4):619-32. PubMed ID: 20477603
[TBL] [Abstract][Full Text] [Related]
25. Etanercept in arthritis.
Scott DL
Int J Clin Pract; 2005 Jan; 59(1):114-8. PubMed ID: 15707475
[TBL] [Abstract][Full Text] [Related]
26. Emerging biologic drugs for the treatment of rheumatoid arthritis.
Puppo F; Murdaca G; Ghio M; Indiveri F
Autoimmun Rev; 2005 Nov; 4(8):537-41. PubMed ID: 16214092
[TBL] [Abstract][Full Text] [Related]
27. Mirthful laughter differentially affects serum pro- and anti-inflammatory cytokine levels depending on the level of disease activity in patients with rheumatoid arthritis.
Matsuzaki T; Nakajima A; Ishigami S; Tanno M; Yoshino S
Rheumatology (Oxford); 2006 Feb; 45(2):182-6. PubMed ID: 16319105
[TBL] [Abstract][Full Text] [Related]
28. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
Christodoulou C; Choy EH
Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
[TBL] [Abstract][Full Text] [Related]
29. Emerging targets of biologic therapies for rheumatoid arthritis.
Tarner IH; Müller-Ladner U; Gay S
Nat Clin Pract Rheumatol; 2007 Jun; 3(6):336-45. PubMed ID: 17538565
[TBL] [Abstract][Full Text] [Related]
30. Cytokinin panel in rheumatoid arthritis and correlation with histological patterns of synovitis -- active type of disease.
Avrămescu C; Vere CC; Mărgăritescu C; Turculeanu A; Bălăşoiu M; Rogoz S
Rom J Morphol Embryol; 2005; 46(2):87-92. PubMed ID: 16286991
[TBL] [Abstract][Full Text] [Related]
31. Angio-oedema in a patient treated with etanercept for rheumatoid arthritis.
Sendur OF; Turan Y; Berkit IK; Tastaban E
Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):488-90. PubMed ID: 19371261
[TBL] [Abstract][Full Text] [Related]
32. Melanoma inhibitory activity, a biomarker related to chondrocyte anabolism, is reversibly suppressed by proinflammatory cytokines in rheumatoid arthritis.
Vandooren B; Cantaert T; van Lierop MJ; Bos E; De Rycke L; Veys EM; De Keyser F; Bresnihan B; Luyten FP; Verdonk PC; Tak PP; Boots AH; Baeten D
Ann Rheum Dis; 2009 Jun; 68(6):1044-50. PubMed ID: 18633128
[TBL] [Abstract][Full Text] [Related]
33. IL-33: a promising therapeutic target for rheumatoid arthritis?
Yuan FL; Li X; Lu WG; Li CW; Xu RS; Dong J
Expert Opin Ther Targets; 2011 May; 15(5):529-34. PubMed ID: 21446881
[TBL] [Abstract][Full Text] [Related]
34. Is IL-1 a good therapeutic target in the treatment of arthritis?
Burger D; Dayer JM; Palmer G; Gabay C
Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):879-96. PubMed ID: 16980212
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect of triptolide on interleukin-18 and its receptor in rheumatoid arthritis synovial fibroblasts.
Lu Y; Wang WJ; Leng JH; Cheng LF; Feng L; Yao HP
Inflamm Res; 2008 Jun; 57(6):260-5. PubMed ID: 18516710
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-7 deficiency in rheumatoid arthritis.
Leonard WJ
Arthritis Res Ther; 2005; 7(1):42-3. PubMed ID: 15642153
[TBL] [Abstract][Full Text] [Related]
37. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
[TBL] [Abstract][Full Text] [Related]
38. [Rheumatoid arthritis, inflammation, and atherosclerosis].
Hürlimann D; Enseleit F; Ruschitzka F
Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
[TBL] [Abstract][Full Text] [Related]
39. LILRA5 is expressed by synovial tissue macrophages in rheumatoid arthritis, selectively induces pro-inflammatory cytokines and IL-10 and is regulated by TNF-alpha, IL-10 and IFN-gamma.
Mitchell A; Rentero C; Endoh Y; Hsu K; Gaus K; Geczy C; McNeil HP; Borges L; Tedla N
Eur J Immunol; 2008 Dec; 38(12):3459-73. PubMed ID: 19009525
[TBL] [Abstract][Full Text] [Related]
40. Treatment of rheumatoid arthritis with rituximab: an update and possible indications.
De Vita S; Quartuccio L
Autoimmun Rev; 2006 Aug; 5(7):443-8. PubMed ID: 16920570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
